Material Transfer agreements
Whenever ‘materials’, such as cell lines, anti-bodies, model systems (plants/animals), databases or other substances, are transferred from one institution or company to another, arrangements on the use of such materials should be covered in a material transfer agreement (MTA) .
The materials should only be used for the purpose the materials were released for. Furthermore, the materials are and continue to be the property of the party providing them. They may not be given to other parties without the consent of the providing party. As a general rule, the party providing the materials also provides a contract template to the second party.
MTA process for IXA VU and VUmc
To properly asses an MTA request, IXA requires you to fill out an intake form. This form contains all relevant information for the legal department to develop/review the agreement. If you have received an MTA from an external party, please include the draft MTA together with IXA’s intake form.
For non-biobank MTA’s, please download and fill in the appropriate intake form and send with the received MTA (if applicable) to IXA.
- If you have received an MTA from the other party and if the materials will be sent by the other party to VUmc, download and fill in the “MTA IN” intake form
- If VUmc is the supplier of the materials, download and fill in the “MTA OUT” intake form
- Fill in your details below and send the intake form to IXA office VU-VUmc
Get to know VU Amsterdam Startup Digi.Bio
Gold Award Winner at Academic Startup Competition and participant in the Digital Mission West Coast USA. Digi.Bio works at the intersection of biology, computation and engineering to develop faster and smarter automation tools that accelerate life science discoveries. MT/Sprout made an interesting video portrait of the award-winning startup. According to co-founder Sabrina Zaini, the VU […]
News
VU spin-off Lumicks raises $93 million for further development of next generation instruments
With an investment of 78 million euros, the Amsterdam-based medical high-tech company LUMICKS is taking a big step forward in the further development of the next generation of instruments for biological research and drug development. The company started in 2014 in the basement of VU Amsterdam. The company now almost has one hundred and fifty […]
News
TKI-PPP grants awarded to Amsterdam UMC researchers
Seventeen researchers of Amsterdam UMC have been awarded a TKI-PPP grant between € 300.000 and € 750.000 to perform a research project in collaboration with an industrial party. The funding is provided by the NL government (Ministry of Economic Affairs) through the Rijksdienst voor Ondernemend Nederland (RVO) and the Topconsortium voor Kennis en Innovatie Life […]
News